Michael Hudecek

33PUBLICATIONS
219CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Apr 10, 2026
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination.

Linda Warmuth, Sarah Dötsch, Manuel Trebo

|Mar 31, 2026
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy.

Umair Munawar, Johanna Thurner, Silvia Nerreter

|Mar 26, 2026
Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy.

Sofie-Katrin Kadel, Lukas Scheller, Alexander M Leipold

|Dec 19, 2025
Vitamin C Conditioning Generates Tumor-Targeting CAR T Cells with Superior Cytotoxicity and Fitness in a Posttransplant Lymphoproliferative Disorder Tumor Model.

Pegah Rahmati, Agnes Bonifacius, Anna Christina Dragon

|Oct 10, 2025
Fine tuning towards the next generation of engineered T cells.

Tham T Nguyen, Patrick Ho, Sarah Staudt

|Sep 24, 2025
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe.

Elise R A Pennings, Anne M Spanjaart, Frederick W Thielen

Pageof 6

Frequent Collaborators

13 joint publications

Hermann Einsele

7 joint publications

Martin K Kortüm

7 joint publications

Thomas Nerreter

7 joint publications

Leo Rasche